MaxCyte, Inc. Basic Shares Outstanding (Weighted Average)
MaxCyte, Inc. (MXCT) reported Basic Shares Outstanding (Weighted Average) of 106.82 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- MaxCyte, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 106.82M shares, a 0.39% increase year-over-year.
- MaxCyte, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 106.88M shares, a 0.87% increase year-over-year.
- MaxCyte, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 106.74M shares, a 1.12% increase year-over-year.
- MaxCyte, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 106.61M shares, a 1.43% increase year-over-year.
- MaxCyte, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 106.43M shares, a 1.51% increase from fiscal 2024.
- MaxCyte, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 104.85M shares, a 1.53% increase from fiscal 2023.
- MaxCyte, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 103.27M shares, a 1.54% increase from fiscal 2022.
- MaxCyte, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 101.70M shares, a 12.23% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 106.82M shares 10-Q · filed 2026-08-13 | 106.85M shares 10-Q · filed 2026-08-13 | 106.81M shares derived: average of 3 quarters · filed 2026-08-13 | 106.76M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | 106.88M shares 10-Q · filed 2026-05-13 | 106.81M shares derived: average of 2 quarters · filed 2026-05-13 | 106.74M shares derived: average of 3 quarters · filed 2026-05-13 | 106.66M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | 106.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 106.68M shares derived: average of 2 quarters · filed 2026-03-25 | 106.58M shares derived: average of 3 quarters · filed 2026-08-13 | 106.43M shares 10-K · filed 2026-03-25 | |
| 2025-09-30 | 106.61M shares 10-Q · filed 2025-11-13 | 106.51M shares derived: average of 2 quarters · filed 2026-08-13 | 106.32M shares 10-Q · filed 2025-11-13 | 106.13M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | 106.40M shares 10-Q · filed 2026-08-13 | 106.18M shares 10-Q · filed 2026-08-13 | 105.97M shares derived: average of 3 quarters · filed 2026-08-13 | 105.75M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | 105.95M shares 10-Q · filed 2026-05-13 | 105.75M shares derived: average of 2 quarters · filed 2026-05-13 | 105.54M shares derived: average of 3 quarters · filed 2026-05-13 | 105.31M shares derived: average of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | 105.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 105.33M shares derived: average of 2 quarters · filed 2026-03-25 | 105.10M shares derived: average of 3 quarters · filed 2026-03-25 | 104.85M shares 10-K · filed 2026-03-25 | |
| 2024-09-30 | 105.11M shares 10-Q · filed 2025-11-13 | 104.87M shares derived: average of 2 quarters · filed 2025-11-13 | 104.61M shares 10-Q · filed 2025-11-13 | 104.39M shares derived: average of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | 104.64M shares 10-Q · filed 2025-08-06 | 104.36M shares 10-Q · filed 2025-08-06 | 104.15M shares derived: average of 3 quarters · filed 2025-08-06 | 103.97M shares derived: average of 4 quarters · filed 2025-08-06 | |
| 2024-03-31 | 104.09M shares 10-Q · filed 2025-05-08 | 103.90M shares derived: average of 2 quarters · filed 2025-05-08 | 103.75M shares derived: average of 3 quarters · filed 2025-05-08 | 103.58M shares derived: average of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | 103.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 103.58M shares derived: average of 2 quarters · filed 2025-03-11 | 103.41M shares derived: average of 3 quarters · filed 2025-03-11 | 103.27M shares 10-K · filed 2025-03-11 | |
| 2023-09-30 | 103.45M shares 10-Q · filed 2024-11-06 | 103.26M shares derived: average of 2 quarters · filed 2024-11-06 | 103.12M shares 10-Q · filed 2024-11-06 | 102.88M shares derived: average of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | 103.06M shares 10-Q · filed 2024-08-06 | 102.96M shares 10-Q · filed 2024-08-06 | 102.69M shares derived: average of 3 quarters · filed 2024-08-06 | 102.47M shares derived: average of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | 102.85M shares 10-Q · filed 2024-05-07 | 102.50M shares derived: average of 2 quarters · filed 2024-05-07 | 102.27M shares derived: average of 3 quarters · filed 2024-05-07 | 102.06M shares derived: average of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | 102.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 101.98M shares derived: average of 2 quarters · filed 2024-03-12 | 101.79M shares derived: average of 3 quarters · filed 2024-03-12 | 101.70M shares 10-K · filed 2024-03-12 | |
| 2022-09-30 | 101.81M shares 10-Q · filed 2023-11-08 | 101.62M shares derived: average of 2 quarters · filed 2023-11-08 | 101.56M shares 10-Q · filed 2023-11-08 | 101.37M shares derived: average of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | 101.43M shares 10-Q · filed 2023-08-09 | 101.55M shares 10-Q · filed 2023-08-09 | 101.22M shares derived: average of 3 quarters · filed 2023-08-09 | 99.83M shares derived: average of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | 101.31M shares 10-Q · filed 2023-05-10 | 101.12M shares derived: average of 2 quarters · filed 2023-05-10 | 99.30M shares derived: average of 3 quarters · filed 2023-05-10 | 95.65M shares derived: average of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | 100.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 98.30M shares derived: average of 2 quarters · filed 2023-03-15 | 93.77M shares derived: average of 3 quarters · filed 2023-03-15 | 90.62M shares 10-K · filed 2023-03-15 | |
| 2021-09-30 | 95.66M shares 10-Q · filed 2022-11-09 | 84.71M shares 10-Q · filed 2021-11-10 | 90.18M shares derived: average of 2 quarters · filed 2022-11-09 | 87.18M shares 10-Q · filed 2022-11-09 | 84.70M shares derived: average of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 84.71M shares 10-Q · filed 2022-08-10 | 82.87M shares 10-Q · filed 2022-08-10 | 81.04M shares derived: average of 3 quarters · filed 2022-08-10 | 80.05M shares derived: average of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | 81.00M shares 10-Q · filed 2022-05-09 | 79.21M shares derived: average of 2 quarters · filed 2022-05-09 | 78.50M shares derived: average of 3 quarters · filed 2022-05-09 | 75.34M shares derived: average of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | 77.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | 77.25M shares derived: average of 2 quarters · filed 2022-03-22 | 73.45M shares derived: average of 3 quarters · filed 2022-03-22 | 69.46M shares 10-K · filed 2022-03-22 | |
| 2020-09-30 | 77.09M shares 10-Q · filed 2021-11-10 | 71.46M shares derived: average of 2 quarters · filed 2021-11-10 | 66.81M shares 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | 65.83M shares 10-Q · filed 2021-09-13 | 61.62M shares 10-Q · filed 2021-09-13 | |||
| 2019-12-31 | 56.40M shares 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |